D-0492-2023 Class II Terminated

Recalled by RemedyRepack Inc. — Indiana, PA

Recall Details

Product Type
Drugs
Report Date
April 12, 2023
Initiation Date
March 20, 2023
Termination Date
October 19, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
a) 58 bottles, b) 6 bottles

Product Description

Doxazosin 2 mg tablets, packaged in a) 30-count (NDC 70518-1560-00) and b) 90-count bottles (NDC 70518-1560-01), Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701.

Reason for Recall

cGMP Deviations

Distribution Pattern

RemedyRepack distributed product to consignees nationwide within the United States

Code Information

Lot #: a) J0665197-120522, Exp. Date 12/31/2023; J0642497-082722, Exp. Date 09/30/2023 J0638552-080922, Exp. Date 08/31/2023. Lot #: b) B1808799-081622, Exp. Date 05/31/2024